Analyst initiations: WYE, SSRX, CEL and PTNR


MOST NOTEWORTHY: Wyeth, 3SBio Inc, Cellcom Israel and Partner Communications were today's noteworthy initiations:
  • Citigroup initiated Wyeth (NYSE: WYE) with a Hold rating and $49 target. The firm believes the upside potential from bapineuzumab is masking the company's unfavorable average EPS and revenue growth forecast versus the industry.
  • Piper believes 3SBio Inc (NASDAQ: SSRX) is the market leader in a largely underpenetrated EPO market in China and sees limited downside risk. Shares were assumed with a Buy rating and $12 target.
  • RBC Capital initiated Cellcom Israel (NYSE: CEL) and Partner Communications (NASDAQ: PTNR) with Outperform ratings and targets of $40 and $30, respectively. RBC said they have defensive appeal given their predictable earnings stream.
OTHER INITIATIONS:

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA-135.4012,755.06
NASDAQ-23.722,903.51
S&P 500-12.551,339.40

Last updated: February 10, 2012: 01:57 PM

Hot Stocks

General Electric

18.82-0.31(-1.62)

Alcoa

10.275-0.365(-3.43)

Apple Inc

493.92+0.75(+0.15)

Google Inc 'A'

605.60-5.86(-0.96)

Bank of America

8.075-0.105(-1.28)

Wal-Mart Stores

61.49-0.47(-0.76)

Exxon Mobil Corp

83.53-1.35(-1.59)

Ford

12.405-0.285(-2.25)

Citigroup

32.91-0.75(-2.23)

IBM

191.82-1.31(-0.68)

Yahoo

16.16+0.16(+1.00)

Starbucks

48.65-0.55(-1.12)

Microsoft

30.54-0.23(-0.75)

Home Depot

45.055-0.215(-0.47)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1328900234354 ms.